Lexeo Therapeutics's LX2006 Has A Viable Regulatory Pathway And Timeline

Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar

Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar

Form 8K Ligand Pharmaceuticals Incorporated For: 22 June

Form 8K Ligand Pharmaceuticals Incorporated For: 22 June

Ubiquitin-like proteins NEDD8 and SUMO2 control epithelial homeostasis, regeneration, and inflammation | Science

Stratified epithelial differentiation involves transcriptional and proteomic remodeling. Here, multiomic profiling implicated ubiquitin and related posttranslational networks in differentiation dynamics. Systematic perturbation of ubiquitin-like ...

We’ve uncovered a master gene that switches on human development

We have identified the gene that, when activated, initiates the developmental programme that results in cells forming a human body

Drug could turn MND from terminal to chronic illness

Researchers have developed a drug to target a unique immune receptor, potentially leading to treatments for neurodegenerative diseases in five years.

New synthetic cells tiptoe toward creating life

New synthetic cells tiptoe toward creating life

FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%

The FDA approved Tregzi, Orca Bio's engineered cell therapy, after a 187-patient trial found it cut moderate-to-severe chronic graft-versus-host disease from 44 with standard transplants to 13. The tradeoff patients now face is a newer therapy without years of follow-up data behind it.

Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC Transcript

Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC Transcript

Ozempic Changed Obesity Treatment Forever — but Experts See a Bigger Medical Revolution Still Coming

A June 20, 2026 ScienceDaily report on a Gastroenterology commentary describes how GLP-1 drugs opened the door to a next era combining drugs, minimally invasive procedures, and precision medicine.

Adaptive regulations key to downstream pharma innovations: BPOM

Indonesia's Food and Drug Supervisory Agency (BPOM) said adaptive biotechnology and pharmaceutical regulations are ...

Tumors found to rewire immune cells, may lead to new cancer treatments

Reprogrammed macrophages activated genes that promote the formation of blood vessels within tumors.

SpaceX Is Set to Join the Nasdaq-100 on July 7. Here's Where History Says the Stock Could Trade 1 Year From Now.

Inclusion in the Nasdaq-100 is a big milestone for SpaceX, which recently went public.

DoH, Arbor Biotechnologies partner to advance gene-editing therapies for rare, genetic diseases

DoH, Arbor Biotechnologies partner to advance gene-editing therapies for rare, genetic diseases

The Surprising Way Microplastics May Influence Inflammation & Allergies

When pollen meets plastic

Invasive Breast Cancer Being Driven By Obesity As Per New Study

Obesity could be associated with a distinct molecular process driving higher chances of invasive breast cancer, according to a new study.

Orforglipron is a new drug that has proven more effective for weight loss and blood sugar control than injectible semaglutides. Bonus: comes in a daily pill, is cheaper to produce, and the name automatically invokes Rule 34 [Interesting]

[link] [24 comments]

MAGA Rep. Mocked Over Bonkers ‘Transgender Mice’ Bill

Justin Sullivan / Getty ImagesSouth Carolina Rep. Nancy Mace is drawing ridicule after unveiling a bill aimed at cracking down on federal funding of “transgender mice.”Mace, 48, announced her “TRANS MICE Act” legislation on X Thursday, but was swiftly hit with a Community Note suggesting she had misunderstood the research the bill seeks to target.“‘Trans mice’ refers to transgenic mice not transgender mice. Transgenic mice are defined as mice that have incorporated foreign DNA into their genome, allowing for the study of gene function and disease mechanisms, particularly in cancer research,” it read.Read more at The Daily Beast.

Contributor: Mental health care isn't ready for psychedelic side effects

Accelerated FDA approval will invite recklessness. But don't block these important medications. Take steps to prepare.

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.

Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence

Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence

Matica Bio, VaxDome partner on antiviral hybrid vaccine development

Matica Biotechnology, the US contract development and manufacturing organization subsidiary of CHA Biotech, has partnered with Texas-based VaxDome Inc. to jointly develop an antigen-agnostic antiviral vaccine aimed at protecting against a broad range of infectious diseases. The collaboration will focus on advancing VaxDome's hybrid antiviral vaccine candidates into clinical trials. Under the agreement, Matica Biotechnology will provide process development, analytical development and the producti

Business : Abaxx Approves CIX As Custodian For Carbon Futures Contract

KUALA LUMPUR, July 9 (Bernama) -- Abaxx Technologies Inc announced that Climate Impact X (CIX), a global environmental markets exchange, has been approved as an eligible custodian for Abaxx Exchange’s carbon futures contracts.

xAI is now officially known as SpaceXAI

The xAI account on X has announced its official rebranding to SpaceXAI, five months after it merged with SpaceX.

Study: Chronic Stress Ages Immune System via Gut-Brain-Bone Marrow Axis, Mouse Data Shows

(NaturalNews) Chronic psychological stress in mice drove blood stem cells to behave as if from an older organism, reducing their ability to self-renew and produce i...

Biohacker Bryan Johnson reveals incurable stomach condition

Biohacker and former tech CEO Bryan Johnson says he has autoimmune gastritis and calls it "incurable," vowing to find a cure. Read more: https://tinyurl.com/ykc3sefr Sign up for our newsletter for the day's top stories, from sports to movies to politics to world events: https://profile.usatoday.com/newsletters/daily-briefing/

Exclusive: Fi is bringing Starlink satellite technology to dog collars

Fi is launching the first pet tracker powered by SpaceX's direct-to-cell satellites, bringing satellite connectivity to consumer pet tech.

Biohacker Bryan Johnson reveals shocking health diagnosis about incurable autoimmune disease

Biohacker Bryan Johnson reveals shocking health diagnosis about incurable autoimmune disease

Alembic Pharma gets USFDA final approval for Oseltamivir oral suspension

The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Oral Suspension, 6 mg/mL, of Hoffmann-La Roche Inc